{"id":8113,"date":"2023-07-24T16:18:28","date_gmt":"2023-07-24T14:18:28","guid":{"rendered":"http:\/\/www.seventure.fr\/wp-content\/uploads\/2023\/07\/23-ENT-06-EO4010-FPI-AUDREY-study.pdf"},"modified":"2023-07-24T16:18:28","modified_gmt":"2023-07-24T14:18:28","slug":"23-ent-06-eo4010-fpi-audrey-study","status":"inherit","type":"attachment","link":"https:\/\/www.seventure.fr\/en\/enterome-announces-first-patient-dosed-in-a-phase-1-2-trial-with-third-oncomimics-immunotherapy-eo4010-in-metastatic-colorectal-cancer\/23-ent-06-eo4010-fpi-audrey-study\/","title":{"rendered":"23-ENT-06-EO4010-FPI-AUDREY-study"},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false},"class_list":["post-8113","attachment","type-attachment","status-inherit","hentry"],"acf":[],"yoast_head":"\n